The Saudi Arabia total parenteral nutrition market size was valued at USD 94.64 million in 2024 and is projected to USD 155.64 million by 2033, growing at a CAGR of 5.71% from 2025 to 2033. The rising prevalence of chronic diseases and the increasing number of premature births are significant factors contributing to market growth. In addition, growing healthcare infrastructure and health system reforms are some other factors fueling market growth further.
The growing prevalence of chronic and lifestyle diseases in Saudi Arabia is a key driver of the Total Parenteral Nutrition (TPN) market. According to a systematic review published in the Saudi Pharmaceutical Journal in November 2024, titled "A Systematic Review of Obesity Burden in Saudi Arabia: Prevalence and Associated Co-Morbidities," the prevalence of obesity among adults and adolescents in Saudi Arabia ranges from 20% to 39%, respectively. The study also highlights the most common obesity-related complications (ORCs), with hypertension affecting 67.6%, type 2 diabetes impacting 60.7%, and hypercholesterolaemia observed in 51.3% of the population.
In addition, the Ministry of Health and the Gulf Health Council state that the four primary non-communicable diseases, such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases, cause around 22,000 deaths in the country, accounting for 35% of the total deaths in the country. Furthermore, the incidence of cancer is also rising, with 28,113 new cases reported in 2022, further highlighting the pressing healthcare challenges facing Saudi Arabia. Thus, the clinical significance of these trends is reflected in rapidly escalating demand for advanced inpatient, outpatient, and home-based nutritional therapies.
Furthermore, the rising number of premature births is a key factor contributing to the growth of the Saudi Arabia total parenteral nutrition (TPN) market due to the specialized medical care required for preterm infants. In Saudi Arabia, premature birth remains a significant public health issue, contributing to neonatal morbidity and placing a strain on healthcare resources. A research article published in the PubMed Central Journal in November 2024 reported a pooled preterm birth prevalence of 7.89 per 100 live births for single pregnancies in the Saudi population. Alarmingly, this rate rises to 91.3 per 100 live births for multiple pregnancies. These statistics, derived from a thorough review of electronic medical records in major cities such as Riyadh, Al-Khobar, Abha, and Jeddah, underscore the substantial burden that preterm birth places on the national healthcare system.
Moreover, the expansion of healthcare infrastructure and ongoing health system reforms are core drivers of the Total Parenteral Nutrition (TPN) market in Saudi Arabia. As part of the Vision 2030 initiative, the Kingdom is undertaking a comprehensive modernization strategy aimed at expanding hospital networks, critical care units, and specialized nutrition centers to meet the evolving needs of its population. The government is placing increasing emphasis on enhancing healthcare facilities to accommodate this growth.
According to the General Authority for Statistics, in 2023, the total number of hospitals in Saudi Arabia was 499, with 23.8 hospital beds per 10,000 people. This rapid expansion of infrastructure supports the broader adoption of TPN by facilitating advanced pharmacy compounding, establishing dedicated clinical nutrition departments, and enabling seamless integration between inpatient and outpatient services.
This product will be delivered within 1-3 business days.
The growing prevalence of chronic and lifestyle diseases in Saudi Arabia is a key driver of the Total Parenteral Nutrition (TPN) market. According to a systematic review published in the Saudi Pharmaceutical Journal in November 2024, titled "A Systematic Review of Obesity Burden in Saudi Arabia: Prevalence and Associated Co-Morbidities," the prevalence of obesity among adults and adolescents in Saudi Arabia ranges from 20% to 39%, respectively. The study also highlights the most common obesity-related complications (ORCs), with hypertension affecting 67.6%, type 2 diabetes impacting 60.7%, and hypercholesterolaemia observed in 51.3% of the population.
In addition, the Ministry of Health and the Gulf Health Council state that the four primary non-communicable diseases, such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases, cause around 22,000 deaths in the country, accounting for 35% of the total deaths in the country. Furthermore, the incidence of cancer is also rising, with 28,113 new cases reported in 2022, further highlighting the pressing healthcare challenges facing Saudi Arabia. Thus, the clinical significance of these trends is reflected in rapidly escalating demand for advanced inpatient, outpatient, and home-based nutritional therapies.
Furthermore, the rising number of premature births is a key factor contributing to the growth of the Saudi Arabia total parenteral nutrition (TPN) market due to the specialized medical care required for preterm infants. In Saudi Arabia, premature birth remains a significant public health issue, contributing to neonatal morbidity and placing a strain on healthcare resources. A research article published in the PubMed Central Journal in November 2024 reported a pooled preterm birth prevalence of 7.89 per 100 live births for single pregnancies in the Saudi population. Alarmingly, this rate rises to 91.3 per 100 live births for multiple pregnancies. These statistics, derived from a thorough review of electronic medical records in major cities such as Riyadh, Al-Khobar, Abha, and Jeddah, underscore the substantial burden that preterm birth places on the national healthcare system.
Moreover, the expansion of healthcare infrastructure and ongoing health system reforms are core drivers of the Total Parenteral Nutrition (TPN) market in Saudi Arabia. As part of the Vision 2030 initiative, the Kingdom is undertaking a comprehensive modernization strategy aimed at expanding hospital networks, critical care units, and specialized nutrition centers to meet the evolving needs of its population. The government is placing increasing emphasis on enhancing healthcare facilities to accommodate this growth.
According to the General Authority for Statistics, in 2023, the total number of hospitals in Saudi Arabia was 499, with 23.8 hospital beds per 10,000 people. This rapid expansion of infrastructure supports the broader adoption of TPN by facilitating advanced pharmacy compounding, establishing dedicated clinical nutrition departments, and enabling seamless integration between inpatient and outpatient services.
Saudi Arabia Total Parenteral Nutrition Market Report Segmentation
This report forecasts, revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented Saudi Arabia total parenteral nutrition market report based on product, region, packaging volume, customer, and end use.Product Outlook (Revenue, USD Million, 2021-2033)
- Premix TPN bags used by hospitals for internal compounding
- Premix TPN bags used directly by hospitals
- Compounded TPN bags prepared in-house by hospitals
- Compounded TPN bags supplied to hospitals by third-party manufacturers
Region Outlook (Revenue, USD Million, 2021-2033)
- Central
- Western
- Eastern
- Southern
- Northern
Packaging Volume Outlook (Revenue, USD Million, 2021-2033)
- >1 L
- 500 mL
- 250 mL
- < 100 mL
Customer Outlook (Revenue, USD Million, 2021-2033)
- B2G
- B2B
- B2C
End Use Outlook (Revenue, USD Million, 2021-2033)
- Adult Patients
- Pediatric & Neonatal Patients
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Saudi Arabia Total Parenteral Nutrition (TPN) Market Variables, Trends & Scope
Chapter 4. Saudi Arabia Total Parenteral Nutrition (TPN) Market: Product Estimates & Trend Analysis
Chapter 5. Saudi Arabia Total Parenteral Nutrition (TPN) Market: Region Estimates & Trend Analysis
Chapter 6. Saudi Arabia Total Parenteral Nutrition (TPN) Market: Packaging Volume Estimates & Trend Analysis
Chapter 7. Saudi Arabia Total Parenteral Nutrition (TPN) Market: Customer Estimates & Trend Analysis
Chapter 8. Saudi Arabia Total Parenteral Nutrition (TPN) Market: End Use Estimates & Trend Analysis
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The key companies profiled in this Saudi Arabia Total Parenteral Nutrition market report include:- Ministry of National Guard Health Affairs (MNGHA) (King Abdulaziz Medical City-Jeddah)
- King Faisal Specialist Hospital and Research Center
- King Saud University Medical City
- King Salman Hospital
- Al Mouwasat
- Saudi Center for Total Parenteral Nutrition (SCTPN)
- Dr. Soliman Fakeeh Hospital, Jeddah
- Armed Forces Hospital Southern Region
- Baxter International Inc.
- Fresenius Kabi AG
- B. Braun Medical Inc.
- Grifols, S.A.
- Aculife (Nirma Limited)
- Pfizer
- Pharmaceutical Solutions Industry (PSI)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | November 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 94.64 Million |
| Forecasted Market Value ( USD | $ 155.64 Million |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Saudi Arabia |
| No. of Companies Mentioned | 16 |
